Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort study.
Ming-Lun YehPo-Cheng LiangChing-I HuangMeng-Hsuan HsiehYi-Hung LinTyng-Yuang JangYu-Ju WeiPo-Yau HsuCheng-Ting HsuChih-Wen WangMing-Yen HsiehZu-Yau LinShinn-Cherng ChenChung-Feng HuangJee-Fu HuangChia-Yen DaiWan-Long ChuangMing-Lung YuPublished in: Journal of gastroenterology and hepatology (2021)
Subjects with resolved HBV infection were at a minimal risk of HBsAg seroreversion, unless with prior anti-HBV treatment experience. Fortunately, even with a reappearance of HBsAg, it was transient and clinically non-relevant.